Status:
COMPLETED
International Study to Evaluate Outcomes and Safety of Patients Undergoing ERCP Using a Single-use Cholangioscope and Single-use Duodenoscope
Lead Sponsor:
Istituto Clinico Humanitas
Conditions:
Biliary Condition
Eligibility:
All Genders
18+ years
Brief Summary
Since its introduction more than 40 years ago, endoscopic retrograde cholangiopancreatography (ERCP) has fundamentally changed the treatment of biliopancreatic diseases. Since late 1970s there have be...
Eligibility Criteria
Inclusion
- \- patients that required an ERCP with cholangioscopy performed with the single-use EXALT duodenoscope in combination with the Spyglass DS II
Exclusion
- Age \< 18
- Lack of follow-up data (30 days at least)
- Less than 3 cases performed during the study period
Key Trial Info
Start Date :
January 27 2021
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
July 31 2021
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT04712253
Start Date
January 27 2021
End Date
July 31 2021
Last Update
September 21 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Endoscopy Unit, Humanitas Research Hospital
Rozzano, Milano, Italy, 20089